BIOA BioAge Labs, Inc. - Common Stock
$16.52
Price · May 20, 2026
Fundamentals as of May 8, 2026
52W Range
$4–$24
63% of range
Analyst Rating
STRONG BUY
13 analysts
Price Target
$51
+211% upside
P/E (TTM)
-5.9
ROE
-28.4%
Net Profit Margin
-896.1%
BIOA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$16.52
Market Cap
$495M
P/E (TTM)
-5.9
EPS (TTM)
$-2.24
Revenue (TTM)
$9M
Div Yield
—
ROE
-28.4%
Debt/Equity
0.0
52W Range
$4 – $24
BIOA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$9M
2024-12-31
→
2025-12-31
EPS
$-2.24
2023-12-31
→
2025-12-31
Free Cash Flow
$-82M
2024-12-31
→
2025-12-31
Margins
-896.1%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
BIOA
Peer Median
P/E (TTM)
-5.9
42.1
P/S (TTM)
55.0
11.8
P/B
1.8
3.4
EV / EBITDA
-2.3
—
Price / FCF
-6.0
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
BIOA
Peer Median
Operating Margin
-1031.5%
—
Net Profit Margin
-896.1%
-5.7%
ROA
-24.7%
-5.4%
ROE
-28.4%
-23.4%
ROIC
-33.8%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
BIOA
Peer Median
Debt / Equity
0.0
—
Current Ratio
14.2
4.0
Quick Ratio
14.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
BIOA
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
BIOA
Peer Median
BIOA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
13 analysts
- Strong Buy 5 38.5%
- Buy 5 38.5%
- Hold 3 23.1%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
7 analysts · 2026-05-18
Median
$52.00
← Below all targets
$16.52
Low
$23.00
High
$73.00
Median target
$52.00
+214.8%
Mean target
$51.43
+211.3%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.07%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.52 | $-0.65 | 0.13% |
| Dec. 31, 2025 | $-0.72 | $-0.75 | 0.03% |
| Sept. 30, 2025 | $-0.56 | $-0.60 | 0.04% |
| June 30, 2025 | $-0.60 | $-0.49 | -0.11% |
| March 31, 2025 | $-0.36 | $-0.54 | 0.18% |
| Dec. 31, 2024 | $-1.97 | $-2.12 | 0.15% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| BIOA | $495M | -5.9 | — | -896.1% | -28.4% | — |
| ESPR | — | -33.6 | 21.3% | -5.6% | 6.2% | — |
| LBRX | $563M | -7.1 | — | — | -25.5% | — |
| AMPH | $1.22B | 13.2 | -1.7% | 13.6% | 12.7% | 49.5% |
| RLMD | $354M | -3.3 | 93.7% | — | -112.0% | — |
| SGP | — | — | — | — | 50.0% | — |
| ANRO | $568M | -8.1 | — | — | -46.1% | — |
| ACRS | $363M | -5.7 | -58.2% | -829.6% | -55.3% | — |
| CRMD | $922M | 5.7 | 617.0% | 52.3% | 52.1% | 88.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $9M | $0 | |
| R&D Expense | $74M | $59M | |
| SG&A Expense | $28M | $19M | |
| Operating Expenses | $102M | $78M | |
| Operating Income | $-93M | $-78M | |
| Other Non-op | $12M | $7M | |
| Pretax Income | $-81M | $-71M | |
| Income Tax | $0 | $0 | |
| Net Income | $-81M | $-71M | |
| EPS (Basic) | $-2.24 | $-6.63 | |
| EPS (Diluted) | $-2.24 | $-6.63 | |
| Shares (Basic) | 35,932,914 | 10,726,521 | |
| Shares (Diluted) | 35,932,914 | 10,726,521 | |
| EBITDA | $-93M | $-78M |
Balance Sheet 23
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $189M | $354M | |
| Short-term Investments | $92M | $0 | |
| Receivables | $769.0K | $0 | |
| Prepaid Expense | $5M | $3M | |
| Current Assets | $287M | $357M | |
| PP&E (Net) | $963.0K | $591.0K | |
| PP&E (Gross) | $1M | $962.0K | |
| Accum. Depreciation | $482.0K | $371.0K | |
| Other Non-current Assets | $216.0K | $240.0K | |
| Total Assets | $295M | $358M | |
| Accounts Payable | $3M | $2M | |
| Current Liabilities | $20M | $28M | |
| Capital Leases | $2M | $0 | |
| Total Liabilities | $23M | $35M | |
| Long-term Debt | $3M | $9M | |
| Total Debt | $3M | $9M | |
| Common Stock | $0 | $0 | |
| Paid-in Capital | $605M | $576M | |
| Retained Earnings | $-333M | $-253M | |
| AOCI | $278.0K | $245.0K | |
| Stockholders' Equity | $272M | $323M | |
| Liabilities + Equity | $295M | $358M | |
| Shares Outstanding | 37,386,908 | 35,850,037 |
Cash Flow 10
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $12M | $7M | |
| Operating Cash Flow | $-82M | $-52M | |
| CapEx | $719.0K | $366.0K | |
| Investing Cash Flow | $-95M | $-366.0K | |
| Stock Issued | $17M | $0 | |
| Net Stock Activity | $17M | · | |
| Financing Cash Flow | $11M | $381M | |
| Net Change in Cash | $-165M | $329M | |
| Taxes Paid | $0 | $0 | |
| Free Cash Flow | $-82M | $-52M |
Profitability 7
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -1031.5% | · | |
| Net Margin | -896.1% | · | |
| Pretax Margin | -896.1% | · | |
| EBITDA Margin | -1031.5% | · | |
| ROA | -24.7% | -37.0% | |
| ROE | -28.4% | -22.3% | |
| ROIC | -33.8% | -23.6% |
Liquidity & Solvency 4
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 14.2 | 12.9 | |
| Quick Ratio | 14.0 | 12.8 | |
| Debt / Equity | 0.0 | 0.0 | |
| LT Debt / Equity | 0.0 | 0.0 |
Efficiency 2
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.0 | · | |
| Receivables Turnover | 23.4 | · |
Valuation (TTM) 14
| Metric | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $9M | $0 | |
| Net Income TTM | $-81M | $-71M | |
| Market Cap | $495M | $208M | |
| Enterprise Value | $216M | $-138M | |
| P/E | -5.9 | -0.9 | |
| P/S | 55.0 | · | |
| P/B | 1.8 | 0.6 | |
| P / Tangible Book | 1.8 | 0.6 | |
| P / Cash Flow | -6.1 | -4.0 | |
| P / FCF | -6.0 | -4.0 | |
| EV / EBITDA | -2.3 | 1.8 | |
| EV / FCF | -2.6 | 2.7 | |
| EV / Revenue | 24.0 | · | |
| Earnings Yield | -16.9% | -114.5% |
Income Statement 12
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3M | $3M | $2M | $2M | $1M | $0 | $0 | $0 | |
| R&D Expense | $20M | $24M | $19M | $20M | $11M | $19M | $20M | $10M | |
| SG&A Expense | $8M | $7M | $7M | $7M | $7M | $6M | $5M | $5M | |
| Operating Expenses | $28M | $32M | $25M | $27M | $18M | $25M | $25M | $15M | |
| Operating Income | $-25M | $-28M | $-23M | $-25M | $-16M | $-25M | $-25M | $-15M | |
| Other Non-op | $3M | $2M | $3M | $3M | $4M | $4M | $1M | $2M | |
| Net Income | $-22M | $-26M | $-20M | $-22M | $-13M | $-21M | $-23M | $-14M | |
| EPS (Basic) | $-0.52 | $-0.72 | $-0.56 | $-0.60 | $-0.36 | $15.77 | $-6.70 | $-7.94 | |
| EPS (Diluted) | $-0.52 | $-0.72 | $-0.56 | $-0.60 | $-0.36 | $15.77 | $-6.70 | $-7.94 | |
| Shares (Basic) | 42,480,488 | -71,617,197 | 35,850,037 | 35,850,037 | 35,850,037 | 3,847,464 | 3,494,580 | 1,711,005 | |
| Shares (Diluted) | 42,480,488 | -71,617,197 | 35,850,037 | 35,850,037 | 35,850,037 | 3,847,464 | 3,494,580 | 1,711,005 | |
| EBITDA | $-25M | · | $-23M | $-25M | $-16M | · | $-25M | · |
Balance Sheet 23
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $242M | $189M | $216M | $220M | $257M | $354M | $334M | · | |
| Short-term Investments | $141M | $92M | $70M | $77M | $63M | $0 | · | · | |
| Receivables | $709.0K | $769.0K | $515.0K | $603.0K | $361.0K | $0 | · | · | |
| Prepaid Expense | $8M | $5M | $5M | $4M | $4M | $3M | $2M | · | |
| Current Assets | $392M | $287M | $291M | $302M | $325M | $357M | $336M | · | |
| PP&E (Net) | $1M | $963.0K | $973.0K | $974.0K | $929.0K | $591.0K | $543.0K | · | |
| PP&E (Gross) | $2M | $1M | $1M | $1M | $1M | $962.0K | $1M | · | |
| Accum. Depreciation | $543.0K | $482.0K | $413.0K | $462.0K | $408.0K | $371.0K | $540.0K | · | |
| Other Non-current Assets | $215.0K | $216.0K | $227.0K | $237.0K | $239.0K | $240.0K | · | · | |
| Total Assets | $398M | $295M | $305M | $322M | $344M | $358M | $337M | · | |
| Accounts Payable | $3M | $3M | $5M | $1M | $4M | $2M | $2M | · | |
| Current Liabilities | $16M | $20M | $24M | $23M | $24M | $28M | $19M | · | |
| Capital Leases | $2M | $2M | $2M | $3M | $3M | $0 | · | · | |
| Total Liabilities | $19M | $23M | $28M | $27M | $31M | $35M | $24M | · | |
| Long-term Debt | · | $3M | $4M | $6M | $7M | $9M | $10M | · | |
| Total Debt | $1M | · | $4M | $6M | $7M | · | $10M | · | |
| Common Stock | $0 | $0 | $0 | $0 | · | $0 | · | · | |
| Paid-in Capital | $735M | $605M | $585M | $582M | $579M | $576M | $545M | · | |
| Retained Earnings | $-356M | $-333M | $-307M | $-287M | $-266M | $-253M | $-232M | · | |
| AOCI | $73.0K | $278.0K | $275.0K | $212.0K | $264.0K | $245.0K | $109.0K | · | |
| Stockholders' Equity | $379M | $272M | $277M | $295M | $313M | $323M | $314M | · | |
| Liabilities + Equity | $398M | $295M | $305M | $322M | $344M | $358M | $337M | · | |
| Shares Outstanding | 44,386,785 | 37,386,908 | 35,850,037 | 35,850,037 | 35,850,037 | 35,850,037 | 34,196,821 | · |
Cash Flow 7
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | |
| Operating Cash Flow | $-24M | $-28M | $-16M | $-20M | $-17M | $-5M | $-15M | $-16M | |
| CapEx | $26.0K | $112.0K | $22.0K | $159.0K | $426.0K | $26.0K | $305.0K | $35.0K | |
| Investing Cash Flow | $-47M | $-14M | $13M | $-16M | $-78M | $-26.0K | $-305.0K | $-35.0K | |
| Financing Cash Flow | $124M | $16M | $-2M | $-2M | $-2M | $25M | $191M | $-2M | |
| Net Change in Cash | $53M | $-27M | $-5M | $-37M | $-97M | $20M | $175M | $-18M | |
| Free Cash Flow | $-24M | · | · | · | $-18M | · | · | · |
Profitability 5
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -915.4% | · | -1126.6% | -1027.0% | -1133.4% | · | · | · | |
| Net Margin | -802.8% | · | -982.0% | -894.0% | -891.0% | · | · | · | |
| EBITDA Margin | -915.4% | · | -1126.6% | -1027.0% | -1133.4% | · | · | · | |
| ROA | -6.0% | · | -6.3% | -13.4% | -7.5% | · | -13.9% | · | |
| ROE | -6.4% | · | -6.8% | -14.6% | -8.3% | · | -14.9% | · |
Liquidity & Solvency 4
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 24.8 | · | 11.9 | 13.2 | 13.7 | · | 17.6 | · | |
| Quick Ratio | 24.3 | · | 11.7 | 13.0 | 13.5 | · | 17.5 | · | |
| Debt / Equity | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | |
| LT Debt / Equity | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · |
Efficiency 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | |
| Receivables Turnover | 5.2 | · | 8.0 | 8.0 | 8.0 | · | · | · |
Valuation (TTM) 14
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $9M | · | $6M | $4M | · | · | · | · | |
| Net Income TTM | $-77M | · | $-78M | $-71M | $-63M | · | $-65M | · | |
| Market Cap | $776M | · | $211M | $148M | $135M | · | $711M | · | |
| Enterprise Value | $394M | · | $-71M | $-144M | $-179M | · | $387M | · | |
| P/E | -8.6 | · | -0.7 | -0.3 | -0.2 | · | -0.7 | · | |
| P/S | 89.3 | · | 35.6 | 38.3 | · | · | · | · | |
| P/B | 2.0 | · | 0.8 | 0.5 | 0.4 | · | 2.3 | · | |
| P / Tangible Book | 2.0 | · | 0.8 | 0.5 | 0.4 | · | 2.3 | · | |
| P / Cash Flow | -32.3 | · | · | · | -7.8 | · | · | · | |
| P / FCF | -32.3 | · | · | · | -7.6 | · | · | · | |
| EV / EBITDA | -15.5 | · | 3.1 | 5.8 | 10.9 | · | -15.6 | · | |
| EV / FCF | -16.4 | · | · | · | 10.0 | · | · | · | |
| EV / Revenue | 45.4 | · | -12.0 | -37.2 | · | · | · | · | |
| Earnings Yield | -11.7% | · | -139.8% | -377.7% | -605.3% | · | -149.7% | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Revenue | $9M | $0 | — |
| Operating Margin % | -1031.5% | — | — |
| Net Income | $-81M | $-71M | $-64M |
| Diluted EPS | $-2.24 | $-6.63 | $-38.17 |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Debt / Equity | 0.0 | 0.0 | — |
| Current Ratio | 14.2 | 12.9 | — |
| Quick Ratio | 14.0 | 12.8 | — |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Free Cash Flow | $-82M | $-52M | — |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.